82 Richmond Street East
Toronto, ON M5C 1P1
Canada
https://www.pharmacielo.com
Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno:
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Marc Lustig M.B.A., M.Sc. | Chairman & CEO | 42,28k | N/D | 1974 |
Mr. Ian D. Atacan B.Sc., C.M.A., C.P.A., M.B.A. | CFO, Corporate Secretary & Director | 202,23k | N/D | N/D |
Mr. Andres Felipe Botero | Chief Operating Officer | 213,68k | N/D | N/D |
Dr. Decio Rabelo de Castro Filho | Chief Medical Officer | N/D | N/D | N/D |
PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. The company also offers telemedicine software. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. PharmaCielo Ltd. has strategic partnership with Benuvia Operations, LLC to manufacture cGMP pharmaceutical-grade CBD isolate and related products. PharmaCielo Ltd. is headquartered in Toronto, Canada.
L'ISS Governance QualityScore di PharmaCielo Ltd. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.